Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (13081)	1/8/1998 12:42:00 AM
From: John O'Neill	Read Replies (1) \| Respond to of 32384

I wonder what Bernie's wife thinks about the trade off between cruising Hawaii and the H&Q conference?...maybe this will be the deciding factor. Any of you have thought on a stock MLNM? A very well covered issue showing strength. The deal with Monsanto is interesting --a lot of potential; plus sponsorship by Pfiser I am concerned, though, that Mycogen holds the patent rights to most of what Monsanto is doing with genetic altercation of agricultural products. Dow chemical now has majority in Mycogen and will pursue patent rights to the max. I wonder if this will affect MLNM prospects? Monsanto has been very successful with partnerships with Delkalb Genetics a Delta Pine Land (both involving genitic altercation of agricultural products). Monsant can be ruthless, however, as shown be deals with Calgene Any thoughts?